$FULC Fulcrum Therapeutics, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Fulcrum Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Fulcrum Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Fulcrum Therapeutics, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| 6 Dimensions Capital, L.P. | 10% Owner | 441,071 | 0 | Jul 22 2019 | |||
| Cadavid Diego | SVP Clinical Development | 68,244 | 0 | Jun 26 2020 | |||
| Casdin Capital, LLC | 10% Owner | 464,285 | 0 | Jul 22 2019 | |||
| Collins James J. | Director | 0 | 0 | Jul 18 2019 | |||
| Dorton Katina | Director | 0 | 0 | Jan 06 2020 | |||
| Ezekowitz Alan | Director | 0 | 0 | Dec 07 2020 | |||
| GERAGHTY JAMES A | Director | 0 | 0 | Jun 15 2020 | |||
| GLAXOSMITHKLINE PLC | 1,785,714 | 0 | Jul 24 2019 | ||||
| Gould Robert J | See Remarks | 507,419 | 0 | Mar 17 2021 | |||
| Haviland Kate | Director | 0 | 0 | Jul 18 2019 | |||
| LEVIN MARK J | Director | 5,880,952 | 0 | Jun 15 2020 | |||
| SANOFI-AVENTIS | 10% Owner | 464,285 | 0 | Jul 23 2019 | |||
| Section 32 Fund 2, LP | 10% Owner | 464,285 | 0 | Jul 22 2019 | |||
| Stuart Bryan | See Remarks | 0 | 0 | Apr 02 2021 | |||
| Third Rock Ventures III, L.P. | 10% Owner | 5,880,952 | 0 | Jul 22 2019 | |||
| Third Rock Ventures IV, L.P. | 10% Owner | 2,261,904 | 0 | Jul 22 2019 | |||
| Thomson Peter G. | VP Finance & Accounting | 20,212 | 0 | Feb 24 2021 | |||
| Wallace Owen B. | Chief Scientific Officer | 133,438 | 0 | Sep 14 2020 |